Beacon Roofing, Sunrun, Marchex and Other 13D Filings
Velan Capital and LTE Partners disclosed jointly on Sept. 19 that they added 658,061 shares to their stake in the cancer-focused biopharmaceutical at prices of $4.39 to $4.99 each from Sept. 3 to Sept. 9. The investors now hold a total of 10,161,733 shares, equal to about 11.5% of Progenics’ outstanding stock.
Beacon Roofing, Sunrun, Marchex and Other 13D Filings
Velan Capital and LTE Partners disclosed jointly on Sept. 19 that they added 658,061 shares to their stake in the cancer-focused biopharmaceutical at prices of $4.39 to $4.99 each from Sept. 3 to Sept. 9. The investors now hold a total of 10,161,733 shares, equal to about 11.5% of Progenics’ outstanding stock.